4 free views remaining today

progressive supranuclear palsy

ICD-10 Codes

Related ICD-10:

Description

Progressive Supranuclear Palsy (PSP): A Rare Brain Condition

Progressive supranuclear palsy (PSP) is a rare and degenerative brain disorder that affects various parts of the body, including movement, balance, vision, speech, and swallowing. The condition is characterized by a gradual deterioration of brain cells at the base of the brain, leading to a range of symptoms.

Common Symptoms

  • Balance Issues: People with PSP often experience difficulty walking or maintaining balance, which can lead to frequent falls [1][2].
  • Eye Movement Problems: A lack of control over eye movements is another characteristic symptom, particularly in the downward direction [6].
  • Weakness and Coordination: Weakness of eye movements, mouth, tongue, and throat muscles, as well as slurred speech and difficulty swallowing, are also common symptoms [8].

Progression of Symptoms

PSP is a progressive condition, meaning that symptoms will continue to worsen over time. The disorder affects the supranuclear region of the brain, which controls various bodily functions, including movement, balance, and vision.

Causes and Risk Factors

While the exact cause of PSP is unknown, research suggests that it may be related to genetic factors or environmental triggers. However, more studies are needed to confirm this.

References

  • [1] Feb 13, 2024 — Symptoms of progressive supranuclear palsy include: A loss of balance while walking.
  • [2] by PSP Is · Cited by 2 — Progressive supranuclear palsy (PSP) is a rare condition that affects certain areas of your brain. Common symptoms include balance issues with frequent falls.
  • [6] Another characteristic symptom is lack of control of eye movement. These symptoms are caused by a gradual deterioration of brain cells at the base of the brain.
  • [8] Weakness of eye movements, especially in the downward direction; Weakened movements of the mouth, tongue, and throat; Slurred speech; Difficulty swallowing.

Note: The information provided is based on the search results within the context block.

Additional Characteristics

  • difficulty swallowing
  • slurred speech
  • frequent falls
  • balance issues
  • eye movement problems
  • weakness and coordination
  • loss of balance while walking
  • lack of control over eye movements
  • weakened movements of mouth, tongue, and throat

Signs and Symptoms

Progressive Supranuclear Palsy (PSP) Signs and Symptoms

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder that affects various areas of the brain, leading to a range of symptoms. The following are some common signs and symptoms of PSP:

  • Balance and Movement Issues: People with PSP often experience difficulties with balance, which can lead to unexplained falls or stiffness in the neck and limbs [1][3].
  • Vision Problems: PSP can cause problems with eye movements, leading to double vision or blurred vision [2].
  • Speech and Swallowing Difficulties: Individuals with PSP may struggle with speech and swallowing, making it hard to communicate effectively [4].
  • Stiffness and Slow Movements: Stiffness in the limbs, trunk (axial rigidity), or neck is a common symptom of PSP, which can make everyday activities challenging [5].
  • Facial Expression Changes: A fixed or startled facial expression due to rigid facial muscles is another sign of PSP [6].
  • Loss of Interest and Motivation: People with PSP may experience depression, lack of motivation, and changes in judgment, insight, and problem-solving abilities [4].

It's essential to note that the symptoms of PSP can vary from person to person, and not everyone will experience all of these signs. If you or someone you know is experiencing any of these symptoms, it's crucial to consult a healthcare professional for an accurate diagnosis and proper care.

References:

[1] Feb 13, 2024 — Symptoms get worse over time and may include: Stiffness, especially of the neck, and awkward movements. [2] People with progressive supranuclear palsy (PSP) develop a range of difficulties with balance, movement, vision, speech and swallowing. [3] by PSP Is · Cited by 2 — Progressive supranuclear palsy (PSP) is a rare condition that affects certain areas of your brain. Common symptoms include balance issues with frequent ... [4] Aug 27, 2024 — Symptoms of Progressive Supranuclear Palsy · Depression · Lack of motivation · Changes in judgment, insight, and problem solving · Difficulty ... [5] Progressive Supranuclear Palsy Symptoms · Stiff or slow movements in the limbs, trunk (axial rigidity), or neck · Problems with walking, balance, clumsiness, and ... [6] PSP symptoms · A fixed or startled facial expression due to rigid facial muscles · Decreased interest in previously enjoyable activities · Difficulty swallowing, ...

Additional Symptoms

  • Speech and Swallowing Difficulties
  • Vision Problems
  • Balance and Movement Issues
  • Stiffness and Slow Movements
  • Facial Expression Changes
  • Loss of Interest and Motivation

Diagnostic Tests

Diagnosing Progressive Supranuclear Palsy (PSP) can be challenging due to its similar symptoms with other conditions

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder that affects movement, balance, and vision. Diagnosing PSP can be difficult because its symptoms are often similar to those of other conditions, such as Parkinson's disease.

  • No single test for PSP: Currently, there is no definitive test or brain imaging technique that can confirm the diagnosis of PSP [1].
  • Physical examination and assessment: Diagnosis begins with a thorough physical examination and assessment of the patient's symptoms by a physician familiar with neurodegenerative disorders [3].
  • Imaging tests: Other tests that are done include:
    • A careful neurological examination
    • Cognitive testing
    • Imaging test (such as MRI or CT scans) to evaluate the brain [4]
  • No standard laboratory tests: Routine genetic testing is not indicated, and there are no standard laboratory tests or imaging studies that can confirm PSP [8].
  • Clinical evaluation: The diagnosis of PSPS is made in the context of the history, cognitive examination, and neurological examination [6].

Key points to note:

  • PSP is a sporadic disease, meaning it is not inherited.
  • There are no definitive tests or brain imaging techniques that can confirm PSP.
  • Diagnosis relies on clinical evaluation by a physician familiar with neurodegenerative disorders.

References:

[1] Feb 13, 2024 — It can be difficult to diagnose progressive supranuclear palsy (PSP), as there's no single test for it and it can have similar symptoms to a number of other conditions. [3] Diagnosis begins with a thorough physical examination and assessment of the patient's symptoms. Other tests that are done include: ... [4] Often, a careful neurological examination, cognitive testing, and imaging test are done to evaluate a person suspected of having PSP. [6] The diagnosis of PSPS is made in the context of the history, cognitive examination, and neurological examination. [8] by JB Rowe · 2021 · Cited by 42 — PSP is a sporadic disease, and routine genetic testing is not indicated. However, if there are first degree relatives with a neurodegenerative condition under ...

Additional Diagnostic Tests

  • Cognitive testing
  • Careful neurological examination
  • Imaging test (such as MRI or CT scans)
  • Physical examination and assessment

Treatment

Treatment Options for Progressive Supranuclear Palsy (PSP)

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder that affects movement and balance. While there is no cure for PSP, various treatment options are available to help manage its symptoms.

  • Medications: Several medications have been tried with limited success in managing PSP symptoms. These include:
    • Antiparkinsonian medications [5], which can sometimes help manage motor symptoms.
    • Tricyclic antidepressants [2], which may be used to alleviate certain symptoms.
    • Amantadine and trazodone, which have been tried with limited success [2].
  • Investigational drugs: Researchers are exploring the use of investigational drugs like BMS-986168 in clinical trials [3] to find more effective treatments for PSP.
  • Current research: Studies suggest that AZP2006 treatment showed promising effects after a 3-month-treatment [7], and an open-label extension trial is being considered based on these results.

Challenges in treating PSP

Unfortunately, there is currently no treatment that effectively stops or slows the progression of PSP [6]. Symptoms often do not respond well to medications, making it essential to explore other management strategies.

Key points

  • No cure for progressive supranuclear palsy (PSP) exists.
  • Various medications have been tried with limited success in managing symptoms.
  • Investigational drugs and clinical trials are ongoing to find more effective treatments.
  • Current research suggests promising results from AZP2006 treatment, but further studies are needed.

References:

[1] Feb 13, 2024 — Although there is no cure for progressive supranuclear palsy, treatments are available to help ease symptoms of the disorder. The options ... [2] Jun 6, 2024 — Tricyclic antidepressants have also been used. Other medications that have been tried with limited success include amantadine and trazodone. [3] This is a Phase II trial that investigates whether an investigational drug called BMS-986168 can safely treat patients with Progressive Supranuclear Palsy (PSP) ... [4] No medication or procedure is available to cure progressive supranuclear palsy (PSP) or completely control its symptoms, but strategies and methods can help ... [5] by PSP Is · Cited by 2 — Antiparkinsonian medications are oral (taken by mouth) medicines typically used to help people with Parkinson's disease. They can sometimes help manage ... [6] Aug 27, 2024 — There is currently no treatment that effectively stops or slows the progression of PSP, and symptoms usually do not respond well to medications. [7] Dec 25, 2023 — Conclusion. AZP2006 treatment showed promising effects after a 3-month-treatment. Considering these promising results, an open-labelled ... [8] Sep 3, 2024 — Patients on the PSP trial will have a 75% chance of treatment with an active drug and after one year, all participants will have the opportunity ...

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
Xref MGI. OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:678
core#notation
DOID:678
oboInOwl#hasDbXref
UMLS_CUI:C0038868
IAO_0000115
A movement disease that is characterized by serious and progressive problems with control of gait and balance, along with complex eye movement and thinking problems. It involves gradual deterioration and death of specific volumes of the brain.
oboInOwl#hasExactSynonym
Steele-Richardson-Olszewski syndrome
rdf-schema#label
progressive supranuclear palsy
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_480
relatedICD
http://example.org/icd10/G23.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_12347
owl#annotatedSource
t446307

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.